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Purpose or Objective: Selecting good responders after 
chemoradiation (CRT) for locally advanced rectal cancer 
(LARC) could lead to the omission of total mesorectal 
excision (TME) in patients with pathologic complete response 
(pCR). In the current study, we assessed the value of several 
blood biomarkers associated with the fibrotic response to 
CRT (IGF-1, IGFBP-2, HGF & GDF-15) as markers for general 
fibro-inflammatory response and as tumor response 
predictors in a group of 80 patients. 
 
Material and Methods: ELISA analysis of IGF-1, IGFBP-2, HGF 
and GDF-15 was conducted on prospectively collected serum 
samples of 80 LARC patients on 3 time points (before, during, 
after CRT). The fibro-inflammatory response was scored on 
H&E sections of the resection specimen. Changes in 
concentration were analysed using a Kruskal-Wallis test. 
Correlation of concentration at each time point and the 
difference between these time points (Δ) with fibro-
inflammatory response and tumor response (pCR and ypT0-1) 
were assessed using a Mann-Whitney-U test. 
 
Results: Higher Growth Differentiation Factor 15 (GDF-15) 
concentration before CRT correlated with the presence of a 
fibro-inflammatory response (p = 0.04), but was not observed 
for the other proteins nor for GDF-15 at other time points.  
General increase in GDF-15 concentration during treatment 
(median 0.81 ng/ml before, 2.16 ng/ml during, 2.37 ng/ml 
after CRT; p <0.0001) was measured (Figure 1). Although no 
significant general concentration changes occurred for IGF-1, 
IGFBP-2 or HGF, we did find a correlation between the 
variation in expression of IGFBP-2 during treatment (ΔIGFBP-2 
TP3-TP2) with tumor response (pCR p = 0.02; ypT0-1 p = 
0.02). Other proteins did not correlate with tumor response. 
 
 
 
Conclusion: GDF-15 serum concentration increases during 
CRT for LARC and a higher concentration measured before 
start of treatment is correlated with the presence of a fibro-
inflammatory response. These results suggest that GDF-15 
could be used as an early predictor of fibro-inflammatory 
response and thereby indirectly as predictor for disease-free 
survival. This will be evaluated when follow-up data are 
available for this patient cohort.  
The correlation of variation in expression of IGFBP-2 with 
tumor response (pCR and ypT0-1) opens a novel possibility for 
selecting good responders to CRT. We aim to combine these 
findings with imaging analyses (DW-MRI, PET) at different 
time points during treatment to develop a predictive model 
for selecting LARC patients in whom surgery could be 
omitted. 
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Purpose or Objective: Hypoxia is a common feature in 
prostate cancer and is known to reduce the response to 
radiotherapy. Hypoxic modifiers can to a large extent 
overcome these obstacles, and a proper classification of 
tumors into hypoxic and non-hypoxic fractions is necessary. 
Previously our department has developed a gene profile 
consisting of 15 genes, which demonstrated prognostic and 
predictive impact for hypoxic modification in head and neck 
squamous cell carcinomas (HNSCC). In the current study we 
investigated the 15 gene profile in different prostate cancer 
cell lines. 
 
Material and Methods: For the in vitro experiments the 
prostate cancer cell lines investigated were PC-3, DU-145, 
and LNCaP. Cell lines were cultured under normoxic (21% O2) 
or hypoxic conditions (0% O2) for 24 hours, totRNA was 
extracted and gene expression levels measured by qPCR. 
Individual reference genes were selected (PSMC4, TBP, 
NDFIP1) and applied in the normalization of the relative 
expression levels, together with the reference genes 
previously used in the HNSCC study. For in vivo experiments, 
the PC3 cell line was inoculated on the flank of female NMRI 
nu/nu mice, whereas the LNCaP and DU-145 cell lines were 
inoculated on the flank of severely immunocompromised 
CIEA/NOG mice. Two hypoxia-sensitive tracers (18F-FAZA and 
Pimonidazole) were administered in order to determine 
hypoxic and non-hypoxic regions on excised tumor sections. 
These regions were isolated by laser-assisted microdissection, 
after which totRNA was extracted and gene expression levels 
measured by qPCR. 
 
Results: In the in vitro experiments, all prostate cancer cell 
lines had 14 of the 15 genes induced by hypoxia. The only 
discrepancy was ALDOA, which was not upregulated in the 
hypoxic cells. In vivo experiments are still ongoing but 
preliminary results from PC3 xenografts have been produced. 
These show a hypoxia induced upregulation in 10 out of the 
15 genes, of which 4 were significantly upregulated (ADM, 
ANKRD37, FAM162A, and LOX). 
 
Conclusion: In this study we investigated the 15 gene hypoxic 
profile in three different prostate cancer cell lines. A hypoxia 
dependent induction of genes was observed in both in vitro 
and in vivo experiments. From the performed experiments, 
and looking only at oxygen dependency, it appears that the 
gene profile could be suitable for prostate cancers as well as 
HNSCC. 
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Purpose or Objective: Acute radiotoxicity might put a vital 
threat to the patient and may require interruption or 
